Why the study?
Loss-of-function mutations in LPL or GPIHBP1 cause severe hypertriglyceridemia, but structures for LPL and GPIHBP1 have remained elusive.
Answers are grounded in this paper and cite their sources.
The structural elucidation of the LPL-GPIHBP1 complex provides a mechanistic basis for how GPIHBP1 stabilizes LPL and offers insights into loss-of-function mutations causing severe hypertriglyceridemia.
Lipoprotein lipase (LPL) is responsible for the intravascular processing of triglyceride-rich lipoproteins. The LPL within capillaries is bound to GPIHBP1, an endothelial cell protein with a three-fingered LU domain and an N-terminal intrinsically disordered acidic domain. Loss-of-function mutations in LPL or GPIHBP1 cause severe hypertriglyceridemia (chylomicronemia), but structures for LPL and GPIHBP1 have remained elusive. Inspired by our recent discovery that GPIHBP1’s acidic domain preserves LPL structure and activity, we crystallized an LPL–GPIHBP1 complex and solved its structure. GPIHBP1’s LU domain binds to LPL’s C-terminal domain, largely by hydrophobic interactions. Analysis of electrostatic surfaces revealed that LPL contains a large basic patch spanning its N- and C-terminal domains. GPIHBP1’s acidic domain was not defined in the electron density map but was positioned to interact with LPL’s large basic patch, providing a likely explanation for how GPIHBP1 stabilizes LPL. The LPL–GPIHBP1 structure provides insights into mutations causing chylomicronemia.
No takes yet. Share an insight, caveat, or question.
Birrane et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: